Trials / Unknown
UnknownNCT02593968
Yallaferon in Chinese Population
a Multi-sites, Randomized, Parallel, Placebo-Controlled Clinical, Pilot Study to Evaluated the Efficacy and Safety of Recombinant Human Interferon Alpha-2b Gel (Yallaferon®) in HPV Infection
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Lee's Pharmaceutical Limited · Industry
- Sex
- Female
- Age
- 25 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of Yallaferon in Chinese population with HPV-16 and/or HPV-18.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Recombinant Human Interferon a-2b Gel | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-09-01
- Completion
- 2016-11-01
- First posted
- 2015-11-02
- Last updated
- 2015-11-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02593968. Inclusion in this directory is not an endorsement.